支气管哮喘的药物治疗和相关不良反应

被引：25

作者：

陶雪飞

朱蕾

机构：

[1] 复旦大学附属中山医院呼吸科

来源：

中国呼吸与危重监护杂志 | 2010年 / 9卷 / 06期

关键词：

D O I：

暂无

中图分类号：

R562.25 [];

学科分类号：

摘要：

引用

收藏

页码：654 / 656

页数：3

相关论文

共 7 条

[1]

支气管哮喘非特异性免疫治疗 [J].

赖克方 .

实用医院临床杂志, 2007, (01) :19-21

[2]

The effect of inhaled corticosteroids on Chlamydophila pneumoniae and Mycoplasma pneumoniae infection in children with bronchial asthma [J].

Sasaki, Atsuko ;

Ouchi, Kazunobu ;

Makata, Haruyuki ;

Hashimoto, Kunio ;

Matsubara, Tomoyo ;

Furukawa, Susumu .

JOURNAL OF INFECTION AND CHEMOTHERAPY, 2009, 15 (02) :99-103

[3]

Safety of Inhaled Budesonide Clinical Manifestations of Systemic Corticosteroid-Related Adverse Effects [J].

Christensson, Camilla ;

Thoren, Anders ;

Lindberg, Bengt .

DRUG SAFETY, 2008, 31 (11) :965-988

[4]

Critical appraisal of antileukotriene use in asthma management [J].

Polosa, Riccardo .

CURRENT OPINION IN PULMONARY MEDICINE, 2007, 13 (01) :24-30

[5]

The expanding role of leukotriene receptor antagonists in chronic asthma [J].

Currie, Graerne P. ;

McLaughlin, Kris .

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2006, 97 (06) :731-742

[6]

A review of pregnancy outcomes after exposure to orally inhaled or intranasal budesonide [J].

Gluck, PA ;

Gluck, JC .

CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (07) :1075-1084

[7]

Cortisontherapie heute.[J].Hanns Kaiser.Wiener Klinische Wochenschrift.2003, 1-2